Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$322K Buy
+11,719
New +$385K 0.08% 80
2025
Q3
Sell
-841
Closed -$37K 320
2025
Q2
$37K Buy
+841
New +$38.1K 0.01% 212
2024
Q1
Sell
-4,958
Closed -$172K 286
2023
Q4
$172K Sell
4,958
-5,871
-54% -$202K 0.08% 110
2023
Q3
$392K Buy
10,829
+1,502
+16% +$55.8K 0.22% 66
2023
Q2
$350K Buy
9,327
+40
+0.4% +$1.61K 0.19% 70
2023
Q1
$429K Buy
9,287
+3,380
+57% +$158K 0.27% 58
2022
Q4
$274K Buy
5,907
+414
+8% +$18.8K 0.17% 74
2022
Q3
$240K Buy
5,493
+180
+3% +$8.27K 0.17% 78
2022
Q2
$225K Buy
+5,313
New +$225K 0.14% 86

Other funds holding G

Steph & Co's G Position: Q2 2026 in Review

Steph & Co opened a new position in Genpact (G) in Q2 2026: 11,719 shares worth $322K. The stake represents 0.08% of the portfolio and ranks #80 among its holdings. This is a return to the name: Steph & Co previously reported a position in G as recently as Q2 2025.

Steph & Co first reported a position in G in Q2 2022 and has held it in 9 quarters since. The position peaked at $429K in Q1 2023. 136 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Steph & Co held 11,719 shares of Genpact worth $322K as of Q2 2026.
  • Genpact was a new Steph & Co position in Q2 2026.
  • Genpact made up 0.08% of Steph & Co's portfolio in Q2 2026, its #80 holding.
  • Steph & Co first reported a position in Genpact in Q2 2022 and has held it in 9 quarters since.
  • Steph & Co's Genpact position peaked at $429K in Q1 2023.
  • 136 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Steph & Co's 13F filing for Q2 2026, filed 16 Jul 2026.